GoldenGolden
Advanced Search
EpiBone

EpiBone

EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.

EpiBone is a biotechnology company headquartered in New York City, New York that was founded in 2013 by Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig. CEO and Co-Founder Nina Tandon worked on heart regeneration for her PhD, worked at McKinsey management consultancy and has an MBA.

EpiBone uses a biomedical engineering process that includes 3D printing to create individualized bone grafts using a patients own mesenchymal stem cells grown in the company's custom built bioreactor. The process involves a CT scan to determine the exact size and shape of a needed bone. A precise, personalized scaffold is created. The patient’s stem cells are cultured so that they start becoming bone cells and are placed on the scaffold and remodel into a personalized bone graft that can be implanted.

Pipeline

Phase 1 and 2 clinical trial Investigational New Drug (IND) clearance was granted by the FDA in 2019 for their product EpiBone-Craniomaxillofacial (EB-CMF) as a treatment for ramus continuity defects in the mandible. The product is anatomically correct and manufactured from a patient’s own adipose derived stem cells.

Funding
Grant

On June 12, 2014 EpiBone received an undisclosed amount of funding in the form of a grant from the Partnership Fund for New York City and Breakout Labs.

Convertible Note

On October 1, 2016 EpiBone received a convertible note worth $560 thousand from Plum Alley.

Timeline

November 16, 2020
EpiBone announces the appointment of Robert S. Langer, Sc.D., to its Board of Directors.
May 22, 2019
EpiBone announces that the U.S. Food and Drug Administration (FDA) has granted its Investigational New Drug (IND) clearance to proceed with a Phase 1/2 clinical trial of its lead bone product EpiBone-Craniomaxillofacial (EB-CMF), as a potential treatment for ramus continuity defects in the mandible.
2013
EpiBone was founded by Nina Tandon.

Funding rounds

People

Name
Role
LinkedIn

Cato Laurencin

Advisor

Cliff Schorer

Advisor

Elma Hawkins

Chairman

Gordana Vunjak-Novakovic

Co-Founder & Chief Scientific Advisor

Hank Kucheman

Advisor

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

How a Bone-Growing Startup Lured 66 Investors, Including Peter Thiel

Liz Welch

Web

Why Peter Thiel Invested In New York Biotech Startup EpiBone

Liz Welch

News

Documentaries, videos and podcasts

Title
Date
Link

Nina Tandon CEO and Co Founder EpiBone

May 17, 2018

Nina Tandon: Could tissue engineering mean personalized medicine?

December 6, 2018

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
FORCE Family Office
February 23, 2021
www.prnewswire.com:443
/PRNewswire/ -- FORCE Family Office is honored to have Dr. Robert Langer, MIT Institute Professor, the most cited engineer in history, and a founding investor...
BioSpace
November 16, 2020
BioSpace
EpiBone, Inc., a privately held, clinical-stage regenerative medicine company focused on skeletal reconstruction, announced today the appointment of Robert S. Langer, Sc.D., to its Board of Directors.
EpiBone, Inc.
November 16, 2020
www.prnewswire.com:443
/PRNewswire/ -- EpiBone, Inc., a privately held, clinical-stage regenerative medicine company focused on skeletal reconstruction, announced today the...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.